Skip to main content

Table 2 Changes in the prevalence of abnormal haematological parameters

From: Impact of highly active antiretroviral therapy on hematological indices among HIV-1 infected children at Kenyatta National Hospital-Kenya: retrospective study

Characteristic N = 337 Baseline no (%) 6 months after initiation of HAART no (%) Relative risk (95 % CI) P value
Hb <10 g/dl 121 (35.9) 56 (16.6) 0.56 (0.44, 0.70) <0.0001
MCV <70 fl 104 (31.0) 28 (8.3) 0.37 (0.27, 0.52) <0.0001
MCH <24 pg 154 (46.7) 49 (14.6) 0.45 (0.35, 0.59) <0.0001
Platelets <150,000 67 (20.0) 22 (6.5) 0.46 (0.32, 0.66) <0.0001
WBC <11,000 33 (10.0) 21 (6.2) 0.76 (0.54, 1.08) 0.09
Granulocytes <1000 22 (6.5) 52 (16) 1.48 (1.25, 1.75) <0.0001